Aim To compare clinicopathological variables, management, and outcome of two cohorts of unselected patients treated for colorectal cancer (CRC) at Christchurch Hospital, New Zealand in 1993–94 and 1998–99. Methods Retrospective review from hospital discharge codes, oncology referral database, and histology database. Data was stored in a Microsoft Access database. Results 356 patients in 1993–94 and 317 patients in 1998–99 had a confirmed diagnosis of adenocarcinoma of the colon or rectum. At the minimum follow-up time of 42 months, 54 % (40 % of CRC) of the 356 patients in the first cohort, and 36% (26 % of CRC) of the 317 patients in the second cohort had died. The Kaplan-Meier survival curves showed significant improvement in 1998–99 over...
Regarding the continuous changes in the diagnostic process and treatment of colorectal cancer (CRC),...
The aim was to examine and compare with “national” estimates, receipt of colorectal cancer (CRC) tre...
Dukes' stage is the most powerful indicator of patient outcome for colorectal cancer. Several cancer...
Background: Most survival data in colorectal cancer (CRC) is derived from clinical trials or registe...
<p><b>Background:</b> Most survival data in colorectal cancer (CRC) is derived from clinical trials ...
Aim: National guidelines for colorectal cancer management aim to optimize cancer outcomes irrespect...
A multicentre retrospective audit of outcome of patients undergoing curative resection for rectal ca...
Background: Our aim is to explore the trend of association between the survival rates of colorectal ...
BACKGROUND: Our aim is to explore the trend of association between the survival rates of colorectal ...
Background: Registry data from four major public hospitals indicate trends over three decades from 1...
Background: Little is known about colorectal cancer or colon and rectal cancer. Are they the same di...
BACKGROUND: This study evaluates the surgical morbidity and long-term outcome of colorectal cancer s...
AIM: The incidence of colorectal cancer (CRC) in New Zealand is high by international standards. App...
Introduction: Singapore has one of the highest age-standardized incidence rates for colorectal cance...
To evaluate retrospectively 5-10 year overall survival rate in patients with colorectal cancer treat...
Regarding the continuous changes in the diagnostic process and treatment of colorectal cancer (CRC),...
The aim was to examine and compare with “national” estimates, receipt of colorectal cancer (CRC) tre...
Dukes' stage is the most powerful indicator of patient outcome for colorectal cancer. Several cancer...
Background: Most survival data in colorectal cancer (CRC) is derived from clinical trials or registe...
<p><b>Background:</b> Most survival data in colorectal cancer (CRC) is derived from clinical trials ...
Aim: National guidelines for colorectal cancer management aim to optimize cancer outcomes irrespect...
A multicentre retrospective audit of outcome of patients undergoing curative resection for rectal ca...
Background: Our aim is to explore the trend of association between the survival rates of colorectal ...
BACKGROUND: Our aim is to explore the trend of association between the survival rates of colorectal ...
Background: Registry data from four major public hospitals indicate trends over three decades from 1...
Background: Little is known about colorectal cancer or colon and rectal cancer. Are they the same di...
BACKGROUND: This study evaluates the surgical morbidity and long-term outcome of colorectal cancer s...
AIM: The incidence of colorectal cancer (CRC) in New Zealand is high by international standards. App...
Introduction: Singapore has one of the highest age-standardized incidence rates for colorectal cance...
To evaluate retrospectively 5-10 year overall survival rate in patients with colorectal cancer treat...
Regarding the continuous changes in the diagnostic process and treatment of colorectal cancer (CRC),...
The aim was to examine and compare with “national” estimates, receipt of colorectal cancer (CRC) tre...
Dukes' stage is the most powerful indicator of patient outcome for colorectal cancer. Several cancer...